Rebecca Halperin

Dr. Halperin is broadly interested in developing and applying methods to gain insight from cancer genomic data that can improve our understanding or tumor biology and inform clinical decision-making. Her current research focuses on the following areas 1) improving calling of variants in difficult samples such as tumor samples lacking matched germline samples, 2) integration of variant calls across tumor samples and data types for improved understanding of tumor heterogeneity and functional implications of alterations, 3) application of immunoinformatics methods to help elucidate how the somatic alterations may allow the patient’s immune system to recognize the tumor.

Data Science